Tilray Brands Inc (TLRY)
2.015
-0.46
(-18.61%)
USD |
NASDAQ |
May 01, 16:00
2.02
0.00 (0.00%)
After-Hours: 18:21
Tilray Brands Accounts Receivable (Quarterly): 89.54M for Feb. 29, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 89.54M |
November 30, 2023 | 90.60M |
August 31, 2023 | 82.08M |
May 31, 2023 | 86.23M |
February 28, 2023 | 78.34M |
November 30, 2022 | 89.70M |
August 31, 2022 | 98.35M |
May 31, 2022 | 95.28M |
February 28, 2022 | 89.90M |
November 30, 2021 | 84.58M |
August 31, 2021 | 97.18M |
May 31, 2021 | 87.31M |
February 28, 2021 | 64.27M |
November 30, 2020 | 74.07M |
August 31, 2020 | 63.09M |
May 31, 2020 | 37.93M |
February 29, 2020 | 58.89M |
November 30, 2019 | 45.67M |
August 31, 2019 | 35.36M |
May 31, 2019 | 18.84M |
February 28, 2019 | 33.58M |
November 30, 2018 | 10.40M |
August 31, 2018 | 2.492M |
Date | Value |
---|---|
May 31, 2018 | 2.626M |
February 28, 2018 | 3.415M |
November 30, 2017 | 2.072M |
August 31, 2017 | 0.9996M |
May 31, 2017 | 0.6131M |
February 28, 2017 | 1.546M |
November 30, 2016 | 1.196M |
August 31, 2016 | 1.940M |
May 31, 2016 | 1.364M |
February 29, 2016 | 1.674M |
November 30, 2015 | 1.095M |
August 31, 2015 | 0.2838M |
February 28, 2015 | |
November 30, 2014 | 0.0005M |
August 31, 2014 | 0.0012M |
May 31, 2014 | 0.0037M |
February 28, 2014 | 0.0031M |
November 30, 2013 | 0.0034M |
August 31, 2013 | 0.0022M |
May 31, 2013 | 0.0013M |
February 28, 2013 | 0.0034M |
November 30, 2012 | |
August 31, 2012 | 0.0032M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
18.84M
Minimum
May 2019
98.35M
Maximum
Aug 2022
73.36M
Average
83.33M
Median
Accounts Receivable (Quarterly) Benchmarks
Clever Leaves Holdings Inc | 0.907M |
Flora Growth Corp | 1.984M |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 24.09M |
Edesa Biotech Inc | 0.7436M |